Blood Screening Market Scenario

Rising prevalence of infectious diseases and introduction of newer pathogens, technological advancements in the field of blood screening and increasing demand for donated blood and rising number of blood donations are some of the major factors propelling the blood screening market globally. Furthermore, rising blood donations and government initiatives is also one of the factors propelling the growth of blood screening market. However, stringent regulatory approvals are one of the major factors expected to hamper the global growth of the blood screening market.   

Blood Screening Market Segmentation

The Blood Screening Market is segmented by Product & Service, Technology, End User and Geography. Various Product & Service of blood screening market are Reagents & Kits (NAT Reagents & Kits, Elisa Reagents & Kits and Other Reagents), Instruments and Software & Services. Furthermore, the Technologies studied in the report are Nucleic Acid Testing (NAT) (Transcription-Mediated Amplification and Real-Time Polymerase Chain Reaction (PCR)), Enzyme-Linked Immunosorbent Assays (Chemiluminescence Immunoassays, Fluorescent Immunoassays and Colorimetric Immunoassays), Rapid Tests, Western Blot Assays and Next-Generation Sequencing. Likewise, various End Users of this market are Blood Banks and Hospitals. Based on Geography, the Blood screening Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.

Blood Screening Market by Geography

Geographically, the blood screening market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America dominated the global blood screening market in 2019. The presence of key industry players, increased adoption of blood screening process, stringent FDA regulations for transfusion, and greater patient affordability are responsible for maintaining its position during the forecast period.

Blood Screening Market Key Players

Some of the major players operating in the global blood screening market includes Grifols, F. Hoffmann-La Roche, Abbott Laboratories, BioMérieux, Bio-Rad Laboratories, Becton, Dickson and Company, Danaher Corporation, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, DiaSorin, GE Healthcare, Merck KGaA, Perkinelmer, Bio-Techne, GFE, Trinity Biotech and J. Mitra Diagnostics Pvt. Ltd. c. These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.

Blood Screening Market Report Key Benefits

• The report offers changing market dynamics in the blood screening market, presenting historical, current and projected market size in terms of value (USD Million)
• The report comprises a detailed analysis of the factors that drive and restrict the growth of the global blood screening market.
• The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of blood screening
• It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the blood screening market performance
• Key players within the global blood screening market are profiled to understand the competitor scenario.

Research Objectives of Blood Screening Market Report:

• Analysing the outlook of the market with the recent trends and Porter’s five forces analysis.
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the Blood Screening Market.
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.